Literature DB >> 22412131

Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study.

Sokbom Kang1, Woo Dae Kang, Hyun Hoon Chung, Dae Hoon Jeong, Sang-Soo Seo, Jong-Min Lee, Jae-Kwan Lee, Jae Weon Kim, Seok-Mo Kim, Sang-Yoon Park, Ki Tae Kim.   

Abstract

PURPOSE: The aim of this study was to develop a preoperative risk prediction model for lymph node metastasis in patients with endometrial cancer and to identify a low-risk group before surgery. PATIENTS AND METHODS: The medical records of 360 patients with endometrial cancer who underwent surgical staging were collected from four institutions and were retrospectively reviewed. By using serum CA-125 levels, preoperative biopsy data, and magnetic resonance imaging (MRI) data, a multivariate logistic model was created. Patients whose predicted probability was less than 4% were defined as low risk. The developed model was externally validated in 180 patients from two independent institutions.
RESULTS: Serum CA-125 levels and three MRI parameters (deep myometrial invasion, lymph node enlargement, and extension beyond uterine corpus) were found to be independent risk factors for nodal metastasis. The model classified 53% of patients as part of a low-risk group, and the false negative rate was 1.7%. In the validation cohort, the model classified 43% of patients as low-risk, and the false negative rate was 1.4%. The model showed good discrimination (area under the receiver operator characteristic curve = 0.85) and was calibrated well. The negative likelihood ratio of our low-risk criteria was 0.11 (95% CI, 0.04 to 0.29), which was equivalent to the false-negative rate of 1.3% (95% CI, 0.5% to 3.3%) at the assumed prevalence of nodal metastasis of 10%.
CONCLUSION: Using serum CA-125 and MRI as criteria resulted in the accurate identification of a low-risk group for lymph node metastasis among patients with endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22412131     DOI: 10.1200/JCO.2011.38.2416

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  36 in total

1.  A Prospective Observational Study Evaluating the Accuracy of MRI in Predicting the Extent of Disease in Endometrial Cancer.

Authors:  Gaurav Goel; Anupama Rajanbabu; C J Sandhya; Indu R Nair
Journal:  Indian J Surg Oncol       Date:  2018-12-17

2.  Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Casper Reijnen; Joanna IntHout; Leon F A G Massuger; Fleur Strobbe; Heidi V N Küsters-Vandevelde; Ingfrid S Haldorsen; Marc P L M Snijders; Johanna M A Pijnenborg
Journal:  Oncologist       Date:  2019-06-11

3.  MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1.

Authors:  Hong-Lin Li; Jun-Jie Sun; Hui Ma; Shen-Jia Liu; Na Li; Su-Jie Guo; Yang Shi; Yan-Ying Xu; Zhi-Ying Qi; Yu-Quan Wang; Fang Wang; Rui-Meng Guo; Dong Liu; Feng-Xia Xue
Journal:  Oncol Lett       Date:  2019-07-31       Impact factor: 2.967

4.  Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.

Authors:  Caryn M St Clair; Ane Gerda Z Eriksson; Jennifer A Ducie; Elizabeth L Jewell; Kaled M Alektiar; Martee L Hensley; Robert A Soslow; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  Ann Surg Oncol       Date:  2015-12-29       Impact factor: 5.344

5.  Is mucinous adenocarcinoma of the endometrium a risk factor for lymph node involvement? A multicenter case-control study.

Authors:  Kemal Gungorduk; Aykut Ozdemir; Ibrahim Egemen Ertas; Ilker Selcuk; Ulas Solmaz; Emre Ozgu; Emre Mat; Mehmet Gokcu; Tuba Karadeniz; Serap Akbay; Muzaffer Sanci; Mehmet Mutlu Meydanli; Duygu Ayaz; Tayfun Gungor
Journal:  Int J Clin Oncol       Date:  2014-11-08       Impact factor: 3.402

6.  SIX1 is overexpressed in endometrial carcinoma and promotes the malignant behavior of cancer cells through ERK and AKT signaling.

Authors:  Xiaochuan Xin; Yue Li; Xianghong Yang
Journal:  Oncol Lett       Date:  2016-09-07       Impact factor: 2.967

Review 7.  Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies.

Authors:  Masayuki Futagami; Yoshihito Yokoyama; Muneaki Shimada; Shinya Sato; Etsuko Miyagi; Akiko Tozawa-Ono; Nao Suzuki; Masaki Fujimura; Yoichi Aoki; Satoru Sagae; Toru Sugiyama
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

8.  How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study.

Authors:  Sokbom Kang; Jong-Min Lee; Jae-Kwan Lee; Jae Weon Kim; Chi-Heum Cho; Seok-Mo Kim; Sang-Yoon Park; Chan-Yong Park; Ki-Tae Kim
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

Review 9.  Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.

Authors:  Giorgio Bogani; Sean C Dowdy; William A Cliby; Fabio Ghezzi; Diego Rossetti; Andrea Mariani
Journal:  J Obstet Gynaecol Res       Date:  2014-02       Impact factor: 1.730

10.  Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer.

Authors:  Sokbom Kang; Zachary Thompson; E Claire McClung; Reem Abdallah; Jae K Lee; Jesus Gonzalez-Bosquet; Robert M Wenham; Hye Sook Chon
Journal:  Int J Gynecol Cancer       Date:  2018-02       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.